Insights into Obstructive Sleep Apnea
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".
Deadline for manuscript submissions: closed (23 February 2024) | Viewed by 1270
Special Issue Editor
Interests: internal medicine; pulmonary and critical care; sleep medicine; pulmonary rehabilitation; sleep disordered breathing in patients with advanced lung disease, ICU, hypoventilation and advanced NIV modes of management
Special Issue Information
Dear Colleagues,
This Special Issue focuses on Obstructive Sleep Apnea (OSA), a prevalent and chronic disorder characterized by repetitive apneas and hypopneas during sleep. It is associated with increased morbidity and mortality and is considered a potential etiological factor for cardiometabolic diseases such as hypertension, diabetes mellitus, stroke, insulin resistance, and atrial fibrillation. Diagnosing OSA is complex, requiring overnight sleep monitoring through polysomnography (PSG). However, PSG alone may not fully demonstrate individual susceptibility to systemic effects. Thus, the inclusion of biomarkers and vascular parameters can improve prognosis prediction and treatment response. Serum and salivary biomarkers offer promising tools for ongoing disease severity monitoring.
Various treatment options for OSAS, including continuous positive airway pressure (CPAP), mandibular advancement devices, upper airway (UA) surgery, and hypoglossal nerve stimulation, mainly focus on improving the impaired UA anatomy. While CPAP remains the "gold standard," its compliance rate is low, and knowledge gaps exist regarding targeted therapy for OSAS. Identifying clinical phenotypes and predictive factors is vital to enable personalized treatment for this complex condition.
This Special Issue aims to highlight the recent advances and new perspectives on OSA diagnosis, personalized treatment strategies, and patient follow-up. The goal is to enhance our understanding of OSA and ultimately improve patient outcomes and quality of life. Authors are encouraged to contribute research on clinical phenotypes, predictive factors, and innovative treatments, ultimately striving to improve the management and outcomes of OSAS patients.
Prof. Dr. Kimberly A. Hardin
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
